Moderna applies for European Union coronavirus vaccine authorization covering teens

Second doses for people who received AstraZeneca in BC start today | News

Moderna asks Health Canada for approval to use vaccine in kids 12+

On June 3, Provincial Health Officer Dr. Bonnie Henry announced the Province will proceed with offering patients who received their first COVID-19 immunization of an AstraZeneca vaccine to have either a second dose of AstraZeneca or one of the two mRNA vaccines now available in B.C. - Pfizer/BioNTech and Moderna. Last month, the European drug regulator approved the shot made by Pfizer and BioNTech for children aged 12 to 15.

Moderna has also filed for authorization to use its vaccine under emergency use regulations in the United States and Canada.

Children with COVID-19 mostly develop only mild symptoms or no symptoms, but remain at risk of becoming seriously ill, and can spread the virus.

Peru's presidential runoff election
Her father is serving a 25-year sentence for graft and human rights abuses and remains a divisive figure in Peruvian politics. Both Mr Castillo and Ms Fujimori condemned the attack. "If we don't unite, we can't move the country forward", Castillo said.

It's the second COVID-19 vaccine maker to apply for a license in children in the European Union after BioNTech/Pfizer, whose mRNA vaccine was approved for adolescents on May 28.

Moderna, which is behind one of two mRNA vaccines now approved for use in Canada, announced last month that its late-stage "TeenCOVE" study "met its primary immunogenicity endpoint, successfully bridging immune responses to the adult vaccination".

British Columbians who received the AstraZeneca/COVISHIELD vaccine will have an opportunity to book a second dose in the coming days and weeks at a community pharmacy.

Twenty-one murder plots uncovered by Australian police in worldwide operation against gangs
Australian police were among the first to reveal the sting, called Operation Ironside, on Tuesday. It has led to drug trade arrests in Australia, Asia, South America and the Middle East.

"The vaccine efficacy in the almost 2,500 adolescents who received the Moderna COVID-19 vaccine was observed to be 100% when using the same case definition as in the Phase 3 COVE study in adults", the biotechnology company added.

The vaccine was "generally well tolerated" among adolescents, the company said, adding: "No significant safety concerns have been identified to date".

U.S. Recovered Majority of Ransom Paid in Colonial Pipeline Hack
Before it announced it had lost access to its servers, it raked in $46 million in just the first three months of this year. Department of Justice might not always be able to recover the funds if victims of an attack opt to pay the ransom.

Latest News